SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-002645
Filing Date
2020-08-12
Accepted
2020-08-12 16:30:27
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_10q-063020.htm 10-Q 402704
2 RESEARCH FUNDING AGREEMENT xenetic_10q-ex1001.htm EX-10.1 106670
3 MASTER SERVICES AGREEMENT xenetic_10q-ex1002.htm EX-10.2 236914
4 WORK ORDER xenetic_10q-ex1003.htm EX-10.3 39179
5 CERTIFICATION xenetic_-ex3101.htm EX-31.1 9869
6 CERTIFICATION xenetic_-ex3102.htm EX-31.2 9579
7 CERTIFICATION xenetic_-ex3201.htm EX-32.1 4736
  Complete submission text file 0001683168-20-002645.txt   2364055

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE xbio-20200630.xml EX-101.INS 264640
9 XBRL SCHEMA FILE xbio-20200630.xsd EX-101.SCH 25799
10 XBRL CALCULATION FILE xbio-20200630_cal.xml EX-101.CAL 34607
11 XBRL DEFINITION FILE xbio-20200630_def.xml EX-101.DEF 105709
12 XBRL LABEL FILE xbio-20200630_lab.xml EX-101.LAB 199997
13 XBRL PRESENTATION FILE xbio-20200630_pre.xml EX-101.PRE 157330
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 201095808
SIC: 2834 Pharmaceutical Preparations